Cancer Family
Melanocytic Neoplasm
CI-CAN-00000026Explore in graph →
Non-malignant609 active trials13 approved drugs233 evidence items
- NCIt
- C7058
Loading cancer entity…
Cancer Family
CI-CAN-00000026Explore in graph →
Clinical trials
3,258 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07050940 | Anti PD-1 Plus Postbiotic Versus Anti PD-1 Alone in Locally Advanced or Metastatic, Treatment naïve, Cutaneous Melanoma Study | recruiting | N/A | 35 | Azienda Ospedaliera di PerugiaOTHER | 1 | Jul 3, 2025 | clinicaltrials |
| NCT06643286 | Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma(Melanoma SCP) | recruiting | N/A | 180 | Erasmus Medical CenterOTHER | 1 | Jun 11, 2025 |
| NCT06970236 | Resistance Exercise in Patients With Ocular Melanoma(IHOPE) | recruiting | N/A | 40 | University of ValenciaOTHER | 1 | May 28, 2025 | clinicaltrials |
| NCT04576429 | Immune Profiles Evolution Under Immunotherapy for Melanoma(EPITHEM) | recruiting | N/A | 360 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Apr 6, 2025 | clinicaltrials |
| NCT03888950 | Interim FDG PET-CT in Melanoma Metastatic Patient's Treated by Anti-PD1 Therapy(TEP-ANTI-PD1) | recruiting | N/A | 20 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Mar 19, 2025 | clinicaltrials |
| NCT06488365 | In Vivo Liquid Biopsy of Melanoma (Cytophone)(Cytophone) | recruiting | N/A | 180 | CytoastraINDUSTRY | 1 | Mar 11, 2025 | clinicaltrials |
| NCT04793737 | Precision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases(PROMMEL) | recruiting | N/A | 27 | Karolinska University HospitalOTHER | 1 | Mar 5, 2025 | clinicaltrials |
| NCT06363591 | WoW - Single- vs Two-staged Excisions of Thin Melanoma(WoW) | recruiting | N/A | 2,486 | Vastra Gotaland RegionOTHER_GOV | 1 | Mar 5, 2025 | clinicaltrials |
| NCT05652673 | Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial | recruiting | N/A | 80 | Erasmus Medical CenterOTHER | 1 | Feb 28, 2025 | clinicaltrials |
| NCT06767332 | EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial(FAME) | recruiting | N/A | 30 | Leiden University Medical CenterOTHER | 1 | Jan 9, 2025 | clinicaltrials |
| NCT03116412 | A Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma(TRIM) | recruiting | N/A | 1,300 | Uppsala UniversityOTHER | 1 | Dec 16, 2024 | clinicaltrials |
| NCT03860883 | Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma(MelMarT-II) | recruiting | N/A | 2,998 | Melanoma and Skin Cancer Trials LimitedOTHER | 10 | Nov 27, 2024 | clinicaltrials |
| NCT06666790 | DermaSensor Postmarket Surveillance Study | recruiting | N/A | 396 | DermaSensor, Inc.INDUSTRY | 1 | Oct 31, 2024 | clinicaltrials |
| NCT05878977 | Biomarkers in Immunotherapy of Melanoma | recruiting | N/A | 150 | Institute of Oncology LjubljanaOTHER | 1 | Oct 18, 2024 | clinicaltrials |
| NCT04605146 | Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy(MONITOR) | recruiting | N/A | 100 | Hospices Civils de LyonOTHER | 1 | Oct 16, 2024 | clinicaltrials |
| NCT04498767 | Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)(OligoRARE) | recruiting | N/A | 200 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Aug 26, 2024 | clinicaltrials |
| NCT05478876 | Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract(CYCLE) | recruiting | N/A | 9 | CNAO National Center of Oncological HadrontherapyOTHER | 1 | Aug 21, 2024 | clinicaltrials |
| NCT05649683 | Immunological Functionnal Test Validation to Predict Melanoma Metastatic Patient Response to Checkpoint Inhibitors(mela-quantif) | recruiting | N/A | 60 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Jun 4, 2024 | clinicaltrials |
| NCT05029791 | Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients(COLEMAN) | recruiting | N/A | 100 | Hospices Civils de LyonOTHER | 1 | Dec 15, 2023 | clinicaltrials |
| NCT05570227 | Metabolic Phenotypes in Melanoma(MetaMel) | recruiting | N/A | 240 | Peter MacCallum Cancer Centre, AustraliaOTHER | 1 | Jul 6, 2023 | clinicaltrials |
| NCT05253872 | The MELAcare Study: A New Method for Surveillance of Melanoma Patients | recruiting | N/A | 378 | Herlev and Gentofte HospitalOTHER | 1 | Jun 26, 2023 | clinicaltrials |
| NCT03787056 | Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients(ONCOPRO) | recruiting | N/A | 410 | Hospices Civils de LyonOTHER | 1 | Jul 16, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Jul 3, 2025source: clinicaltrials